March 2026 in “Journal for ImmunoTherapy of Cancer” This paper reports insights from an Expert Panel convened by the Society for Immunotherapy of Cancer on managing immune-related adverse events (irAEs) following immune checkpoint inhibitor therapy, highlighting surveillance gaps and the need for a comprehensive irAE registry to improve post-treatment care for cancer survivors.
October 2025 in “International Journal of Reproduction Contraception Obstetrics and Gynecology” This study found that Myoinositol and D-chiro inositol treatment improved fertility outcomes in women with PCOS, particularly in Phenotypes A and D, but larger studies are needed to confirm these results.
June 2026 in “Dove Medical Press (Taylor and Francis Group)” This paper reviews existing and emerging therapies for alopecia areata, describing the impact of targeted treatments in this field, and introduces a global network of disease registers to study the long-term safety and effectiveness of these new options.
June 2026 in “Journal of Inflammation Research” This narrative review discusses how new targeted therapies, like biologics and small molecules, are transforming alopecia areata treatment and highlights the establishment of the GRASS-UK/GRASS-International network to investigate the long-term safety and effectiveness of these new treatments.
June 2026 in “DOAJ (DOAJ: Directory of Open Access Journals)” This study reviews both traditional and innovative therapies for alopecia areata, focusing on the potential benefits and challenges of newer targeted treatments while introducing GRASS-UK/GRASS-International as networks aimed at assessing the long-term safety and effectiveness of these therapies worldwide.
September 2025 in “Meditsinskiy sovet = Medical Council” This study found a significant age-dependent association between alopecia areata and atopic dermatitis, with atopic dermatitis being a notable risk factor, especially in children.
12 citations
,
November 2023 in “Medicine” This study used bibliometric analysis to evaluate global research on AI applications in dermatology, identifying 406 relevant papers and highlighting current priorities such as machine learning for wound progression, AI in teledermatology, and applications for skin diseases.
July 2023 in “International journal of yogic, human movement and sports sciences” This study comprehensively analyzes a specific disease, detailing its prevalence, diagnostic criteria, and various types and subtypes, aiming to enhance understanding and guide personalized management strategies for improved patient outcomes.
March 2024 in “Dermatology and therapy” This study analyzed data from 2083 patients with alopecia areata in Europe and found that those with atopic, autoimmune, or psychiatric comorbidities encountered more severe disease and were more likely to require advanced treatments compared to those without comorbid conditions.
8 citations
,
October 2021 in “Indian Journal of Plastic Surgery/Indian journal of plastic surgery” This study reviewed data from 2,896 hair transplant patients over 10 years, identifying sterile folliculitis, vasovagal shock, facial edema, and other minor complications, with no life-threatening issues reported. Detailed counseling and thorough medical history assessments are recommended to minimize risks.
39 citations
,
October 2018 in “Aesthetic surgery journal” This review discusses nonsurgical techniques for facial masculinization and feminization in transgender patients and reports no new clinical findings, utilizing data from analogous procedures in cisgender individuals.
This chapter reviews plant extract-based cosmeceuticals for hair care and hair loss but presents no new clinical findings, instead discussing active ingredients with supportive scientific data.
32 citations
,
March 2008 in “SKINmed Dermatology for the Clinician” This review examines the clinical features, histology, and treatment options for various neutrophilic and mixed primary cicatricial alopecias, but presents no new data.
September 2025 in “Dermatology and Therapy” This study reviewed the burden of alopecia areata in the UAE, noting limited regional data on patient demographics and treatments but highlighting the approval and promising results of the Janus kinase inhibitor baricitinib for managing this condition.
6 citations
,
September 2024 in “Current Oncology” This review summarizes evidence and adverse event management recommendations for Sacituzumab Govitecan in metastatic triple-negative breast cancer and hormone receptor-positive breast cancer, emphasizing favorable survival data from clinical trials.
September 2025 in “Headache The Journal of Head and Face Pain” In this critique, the authors argue that the American College of Physicians' recent guideline for migraine preventive therapy is based on a flawed analysis with low confidence levels and outdated data, failing to acknowledge newer migraine-specific therapies with stronger evidence and better tolerability.
July 2026 in “International Journal of Applied Pharmaceutics” This review discusses the dermatological and systemic adverse effects of hair dye use, particularly focusing on the common allergen para-phenylenediamine, and reports no new clinical data.
August 2025 in “OBM Integrative and Complementary Medicine” This review consolidates evidence on 93 plant species used in Zimbabwe for treating 21 skin-related conditions, reporting antimicrobial, anti-inflammatory, and antioxidant properties, though safety data remains inconsistent.
188 citations
,
January 2022 in “PubMed” This review discusses recent advancements in congenital adrenal hyperplasia research, including improved diagnostic techniques, alternative treatments, and insights from long-term outcome data, but it reports no new clinical results.
1 citations
,
April 2022 in “Indian Journal of Plastic Surgery” This article reviews the current understanding and rising prevalence of gender incongruence, detailing the authors' extensive experience with gender affirmative surgeries, but reports no new clinical data.
2 citations
,
June 2025 in “Biomolecules” This review highlights that gut dysbiosis and bacterial extracellular vesicles are key factors in PCOS pathophysiology, and suggests AI-driven analysis of these profiles could enhance diagnostic accuracy and treatment personalization, though ethical concerns like data privacy and bias must be considered.
24 citations
,
January 2004 in “The scientific world journal/TheScientificWorldjournal” This study found that HAIR-AN syndrome is prevalent among young women, and a multifaceted treatment approach effectively reduces symptom severity and prevents further consequences.
December 2023 in “Journal of the Korean Society of Cosmetology” This study found that individual lifestyle factors, such as aesthetic, personality, and social orientations, positively influence appearance interest and beauty management behavior.
16 citations
,
July 2001 in “Dermatologic Clinics” This article reviews the dermabrasion resurfacing technique and details consultation, medication, management practices, and expected outcomes, but it does not present any new clinical data.
1 citations
,
March 2025 in “Skin Appendage Disorders” Healthcare access for alopecia areata in the USA is unequal among ethnic groups.
109 citations
,
December 1998 in “The Journal of Dermatology” This review discusses the hair follicle cycle's complex regulation and highlights the potential for targeting catagen control in future therapies without presenting new experimental data.
79 citations
,
July 2022 in “Sensors” In this study, researchers evaluated various machine learning models for predicting type 2 diabetes risk, finding that Random Forest and K-NN models performed best in terms of precision, recall, accuracy, and other metrics using common symptoms as features.
33 citations
,
June 2016 in “Pediatric Dermatology” This review examines hair shaft disorders, reporting limited evidence for treatments like minoxidil and oral retinoids, and emphasizes gentle hair care and genetic counseling for managing congenital cases.
25 citations
,
March 2018 in “Journal of oncology practice” This study found that scalp cooling effectively reduces chemotherapy-induced hair loss, especially with taxane-based regimens, and recent U.S. trials support its safety, despite logistical and insurance challenges.
January 2026 in “Dermatology and Therapy” This study suggests a possible bidirectional relationship between sleep quality and hair loss, indicating that addressing sleep disturbances might improve hair loss management and patient well-being.